INGN up +4.19% percent right now. $INGN High is at 26.01 and the Low 24.22 with current volume of 145,769.
Recent News posted below.
INGN Inogen Inc Recent Headline News
Inogen to Participate in Stifel 2014 Healthcare Conference
GlobeNewswire - Wed Nov 05, 3:39PM CST
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today the company is scheduled to participate in the Stifel 2014 Healthcare Conference in New York City.
INGN: 24.37 (+0.76)
Inogen Announces Closing of Secondary Public Offering
GlobeNewswire - Tue Nov 04, 3:05PM CST
Inogen, Inc. (Nasdaq:INGN) today announced the closing of 2,415,891 shares of its common stock at $21.50 per share in a secondary offering (including 315,116 shares that were offered and sold by the selling stockholders pursuant to the full exercise of the underwriters' option to purchase additional shares). All of the shares were sold by existing stockholders.
INGN: 24.37 (+0.76)
Nasdaq stocks posting largest volume increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ESBF: 18.72 (+0.06), CRNT: 1.16 (-0.01), RDCM: 9.19 (+0.39), MCGC: 3.66 (unch), BBSI: 24.30 (-0.93), INGN: 24.37 (+0.76), CDTI: 2.60 (+0.10), ATTU: 8.94 (+0.08), HOTR: 2.01 (-0.03), ARCP: 8.55 (-0.24), SMBC: 37.06 (-0.94), XOOM: 14.54 (-0.16)
Inogen Announces Pricing of Secondary Public Offering
GlobeNewswire - Wed Oct 29, 7:45PM CDT
Inogen, Inc. (Nasdaq:INGN) today announced the pricing of 2,100,775 shares of its common stock at $21.50 per share in a secondary offering. All of the shares will be sold by existing stockholders. In addition, the underwriters have a 30-day option to purchase up to 315,116 additional shares of common stock from the selling stockholders.
INGN: 24.37 (+0.76)
Inogen Announces Launch of Proposed Secondary Public Offering by Selling Stockholders
GlobeNewswire - Mon Oct 27, 3:10PM CDT
Inogen, Inc. (Nasdaq:INGN) announced today the launch of a proposed secondary public offering of 2,100,775 shares of its common stock. All of such shares will be offered and sold by certain stockholders of Inogen, and the selling stockholders will receive all of the proceeds from such offering. In addition, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 315,116 shares of common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Inogen will not sell any shares in the offering, nor will it receive any proceeds from the sale of the shares.
JPM: 61.67 (+0.20), INGN: 24.37 (+0.76)
Inogen Announces Preliminary Unaudited Third Quarter 2014 Revenue
GlobeNewswire - Mon Oct 27, 3:10PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it expects to report total revenue of at least $28 million in the third quarter of fiscal year 2014, representing at least 41% year-over-year growth.
INGN: 24.37 (+0.76)
Inogen Announces Release to Market of the Inogen At Home(TM), an Innovative Home Oxygen Concentrator
GlobeNewswire - Tue Oct 21, 7:01AM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it has released to market its innovative home oxygen concentrator called the Inogen At Home(TM).
INGN: 24.37 (+0.76)
Inogen to Announce Third Quarter 2014 Results on Tuesday, November 11, 2014
GlobeNewswire - Tue Oct 14, 3:10PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the third quarter of 2014 after the close of trading on Tuesday, November 11, 2014. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
INGN: 24.37 (+0.76)
Cyberonics Sluggish on Poor Q2, Faces Reimbursement Issues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 4:05PM CDT
On Sep 24, we issued an updated research report on Cyberonics Inc. (CYBX).
INGN: 24.37 (+0.76), EW: 123.96 (+1.20), HOLX: 26.56 (+0.35), CYBX: 50.05 (-0.25)
Inogen Announces Reimbursement for the Inogen One G3 in France
GlobeNewswire - Tue Sep 09, 8:04AM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that the Inogen One G3 portable oxygen concentrator has received coverage for reimbursement within France.
INGN: 24.37 (+0.76)
Inogen (INGN) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 8:31AM CDT
Inogen (INGN) Shares March Higher, Can It Continue?
INGN: 24.37 (+0.76)
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and Echo Therapeutics
PR Newswire - Wed Sep 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Bacterin International Holdings, Inc. (AMEX:BONE-Free Report), Inogen, Inc. (Nasdaq:INGN-Free Report) and Echo Therapeutics, Inc. (Nasdaq:ECTE-Free Report).
ECTE: 0.59 (-0.08), BONE: 4.09 (+0.02), MDT: 68.61 (+0.51), INGN: 24.37 (+0.76)
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
ECTE: 0.59 (-0.08), ZMH: 110.24 (+2.05), BSX: 13.43 (+0.19), BONE: 4.09 (+0.02), MDT: 68.61 (+0.51), COV: 92.73 (+0.65), DGX: 62.84 (+1.15), INGN: 24.37 (+0.76), STJ: 65.64 (+0.88), LH: 100.86 (+0.34), SYK: 88.33 (+0.86)
4 Stocks Breaking Out on Big Volume
at The Street - Tue Aug 26, 6:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
INGN: 24.37 (+0.76), MOBL: 9.49 (+0.14), FNHC: 26.61 (+0.47), ANN: 36.22 (-0.70)
4 Big-Volume Stocks Triggering Breakout Trades
at The Street - Thu Aug 14, 6:00AM CDT
Keep these stocks rising on unusual volume on your breakout trading radar.
GMED: 21.53 (+0.05), INGN: 24.37 (+0.76), PAYC: 21.82 (+0.40), HPTX: 21.47 (-0.35)
Inogen Releases Second Quarter 2014 Financial Results
GlobeNewswire - Tue Aug 12, 4:41PM CDT
- Record Q2 2014 Revenues Reflect 51% Growth over Q2 2013 -
INGN: 24.37 (+0.76)
Inogen Strengthens Board of Directors With Addition of Heather D. Rider
GlobeNewswire - Thu Aug 07, 7:00AM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Heather D. Rider has been elected to its Board of Directors, effective immediately. In addition, Ms. Rider was appointed to the Board's Compensation, Nominating and Governance Committee replacing Benjamin Anderson-Ray who has joined the Board's Audit Committee, effective immediately. She will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held in 2015. Ms. Rider fills the vacancy created by the resignation of Charles Larsen. Mr. Larsen has served as a member of Inogen's Board since 2006.
INGN: 24.37 (+0.76)
Inogen to Release Second Quarter 2014 Financial Results and Host Conference Call on Tuesday, August 12, 2014
GlobeNewswire - Tue Jul 29, 3:11PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it will release its financial results for the second quarter of 2014 after the close of trading on Tuesday, August 12, 2014. The company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
INGN: 24.37 (+0.76)
Inogen Announces FDA Clearance of Innovative Home Oxygen Concentrator
GlobeNewswire - Tue Jun 24, 8:00AM CDT
Inogen, Inc. (Nasdaq:INGN) announced today that it has received FDA clearance for an innovative home oxygen concentrator called the Inogen At Home(TM).
INGN: 24.37 (+0.76)
Inogen Added to Russell 2000(R) and 3000(R) Indexes
GlobeNewswire - Mon Mar 31, 4:20PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions, announced today the company was added to the Russell 2000(R) and Russell 3000(R) Indexes following the reconstitution of Russell Investment Group's family of US indexes after market close on March 31, 2014.
INGN: 24.37 (+0.76)
Recent News posted below.
INGN Inogen Inc Recent Headline News
Inogen to Participate in Stifel 2014 Healthcare Conference
GlobeNewswire - Wed Nov 05, 3:39PM CST
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today the company is scheduled to participate in the Stifel 2014 Healthcare Conference in New York City.
INGN: 24.37 (+0.76)
Inogen Announces Closing of Secondary Public Offering
GlobeNewswire - Tue Nov 04, 3:05PM CST
Inogen, Inc. (Nasdaq:INGN) today announced the closing of 2,415,891 shares of its common stock at $21.50 per share in a secondary offering (including 315,116 shares that were offered and sold by the selling stockholders pursuant to the full exercise of the underwriters' option to purchase additional shares). All of the shares were sold by existing stockholders.
INGN: 24.37 (+0.76)
Nasdaq stocks posting largest volume increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ESBF: 18.72 (+0.06), CRNT: 1.16 (-0.01), RDCM: 9.19 (+0.39), MCGC: 3.66 (unch), BBSI: 24.30 (-0.93), INGN: 24.37 (+0.76), CDTI: 2.60 (+0.10), ATTU: 8.94 (+0.08), HOTR: 2.01 (-0.03), ARCP: 8.55 (-0.24), SMBC: 37.06 (-0.94), XOOM: 14.54 (-0.16)
Inogen Announces Pricing of Secondary Public Offering
GlobeNewswire - Wed Oct 29, 7:45PM CDT
Inogen, Inc. (Nasdaq:INGN) today announced the pricing of 2,100,775 shares of its common stock at $21.50 per share in a secondary offering. All of the shares will be sold by existing stockholders. In addition, the underwriters have a 30-day option to purchase up to 315,116 additional shares of common stock from the selling stockholders.
INGN: 24.37 (+0.76)
Inogen Announces Launch of Proposed Secondary Public Offering by Selling Stockholders
GlobeNewswire - Mon Oct 27, 3:10PM CDT
Inogen, Inc. (Nasdaq:INGN) announced today the launch of a proposed secondary public offering of 2,100,775 shares of its common stock. All of such shares will be offered and sold by certain stockholders of Inogen, and the selling stockholders will receive all of the proceeds from such offering. In addition, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 315,116 shares of common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Inogen will not sell any shares in the offering, nor will it receive any proceeds from the sale of the shares.
JPM: 61.67 (+0.20), INGN: 24.37 (+0.76)
Inogen Announces Preliminary Unaudited Third Quarter 2014 Revenue
GlobeNewswire - Mon Oct 27, 3:10PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it expects to report total revenue of at least $28 million in the third quarter of fiscal year 2014, representing at least 41% year-over-year growth.
INGN: 24.37 (+0.76)
Inogen Announces Release to Market of the Inogen At Home(TM), an Innovative Home Oxygen Concentrator
GlobeNewswire - Tue Oct 21, 7:01AM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it has released to market its innovative home oxygen concentrator called the Inogen At Home(TM).
INGN: 24.37 (+0.76)
Inogen to Announce Third Quarter 2014 Results on Tuesday, November 11, 2014
GlobeNewswire - Tue Oct 14, 3:10PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the third quarter of 2014 after the close of trading on Tuesday, November 11, 2014. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
INGN: 24.37 (+0.76)
Cyberonics Sluggish on Poor Q2, Faces Reimbursement Issues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 4:05PM CDT
On Sep 24, we issued an updated research report on Cyberonics Inc. (CYBX).
INGN: 24.37 (+0.76), EW: 123.96 (+1.20), HOLX: 26.56 (+0.35), CYBX: 50.05 (-0.25)
Inogen Announces Reimbursement for the Inogen One G3 in France
GlobeNewswire - Tue Sep 09, 8:04AM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that the Inogen One G3 portable oxygen concentrator has received coverage for reimbursement within France.
INGN: 24.37 (+0.76)
Inogen (INGN) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 8:31AM CDT
Inogen (INGN) Shares March Higher, Can It Continue?
INGN: 24.37 (+0.76)
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and Echo Therapeutics
PR Newswire - Wed Sep 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Bacterin International Holdings, Inc. (AMEX:BONE-Free Report), Inogen, Inc. (Nasdaq:INGN-Free Report) and Echo Therapeutics, Inc. (Nasdaq:ECTE-Free Report).
ECTE: 0.59 (-0.08), BONE: 4.09 (+0.02), MDT: 68.61 (+0.51), INGN: 24.37 (+0.76)
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
ECTE: 0.59 (-0.08), ZMH: 110.24 (+2.05), BSX: 13.43 (+0.19), BONE: 4.09 (+0.02), MDT: 68.61 (+0.51), COV: 92.73 (+0.65), DGX: 62.84 (+1.15), INGN: 24.37 (+0.76), STJ: 65.64 (+0.88), LH: 100.86 (+0.34), SYK: 88.33 (+0.86)
4 Stocks Breaking Out on Big Volume
at The Street - Tue Aug 26, 6:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
INGN: 24.37 (+0.76), MOBL: 9.49 (+0.14), FNHC: 26.61 (+0.47), ANN: 36.22 (-0.70)
4 Big-Volume Stocks Triggering Breakout Trades
at The Street - Thu Aug 14, 6:00AM CDT
Keep these stocks rising on unusual volume on your breakout trading radar.
GMED: 21.53 (+0.05), INGN: 24.37 (+0.76), PAYC: 21.82 (+0.40), HPTX: 21.47 (-0.35)
Inogen Releases Second Quarter 2014 Financial Results
GlobeNewswire - Tue Aug 12, 4:41PM CDT
- Record Q2 2014 Revenues Reflect 51% Growth over Q2 2013 -
INGN: 24.37 (+0.76)
Inogen Strengthens Board of Directors With Addition of Heather D. Rider
GlobeNewswire - Thu Aug 07, 7:00AM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Heather D. Rider has been elected to its Board of Directors, effective immediately. In addition, Ms. Rider was appointed to the Board's Compensation, Nominating and Governance Committee replacing Benjamin Anderson-Ray who has joined the Board's Audit Committee, effective immediately. She will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held in 2015. Ms. Rider fills the vacancy created by the resignation of Charles Larsen. Mr. Larsen has served as a member of Inogen's Board since 2006.
INGN: 24.37 (+0.76)
Inogen to Release Second Quarter 2014 Financial Results and Host Conference Call on Tuesday, August 12, 2014
GlobeNewswire - Tue Jul 29, 3:11PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it will release its financial results for the second quarter of 2014 after the close of trading on Tuesday, August 12, 2014. The company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
INGN: 24.37 (+0.76)
Inogen Announces FDA Clearance of Innovative Home Oxygen Concentrator
GlobeNewswire - Tue Jun 24, 8:00AM CDT
Inogen, Inc. (Nasdaq:INGN) announced today that it has received FDA clearance for an innovative home oxygen concentrator called the Inogen At Home(TM).
INGN: 24.37 (+0.76)
Inogen Added to Russell 2000(R) and 3000(R) Indexes
GlobeNewswire - Mon Mar 31, 4:20PM CDT
Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions, announced today the company was added to the Russell 2000(R) and Russell 3000(R) Indexes following the reconstitution of Russell Investment Group's family of US indexes after market close on March 31, 2014.
INGN: 24.37 (+0.76)
